AMANOZINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Possibly Marketed Outside US

Details

Stereochemistry	ACHIRAL
Molecular Formula	C9H9N5
Molecular Weight	187.2013
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of AMANOZINE

Structure Search

SMILES

NC1=NC(NC2=CC=CC=C2)=NC=N1

InChI

InChIKey=YMFGJWGABDOFID-UHFFFAOYSA-N

InChI=1S/C9H9N5/c10-8-11-6-12-9(14-8)13-7-4-2-1-3-5-7/h1-6H,(H3,10,11,12,13,14)

HIDE SMILES / InChI

Molecular Formula	C9H9N5
Molecular Weight	187.2013
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13559219 | https://www.drugfuture.com/chemdata/amanozine.html | https://www.drugs.com/international/amanozine.html

Amanozine (W-1191-2) is a triazine diuretic compound.

Approval Year

PubMed

PubMed

Title	Date	PubMed
Observations on amanozine (W-1191-2), a triazine diuretic compound.	1958-07	13559219

Patents

Patents

Substance Class	Chemical Created by `admin` on `Wed Apr 02 10:00:29 GMT 2025` Edited by `admin` on `Wed Apr 02 10:00:29 GMT 2025`
Record UNII	X43W7JDA8L
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

AMANOZINE [MI]

Preferred Name

English

AMANOZINE

Official Name

English

amanozine [INN]

Common Name

English

2-AMINO-4-ANILINO-S-TRIAZINE

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C448

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

Code System Code Type Description

FDA UNII

X43W7JDA8L

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

PRIMARY

SMS_ID

100000087663

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

PRIMARY

INN

802

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

PRIMARY

DRUG CENTRAL

3667

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

PRIMARY

MERCK INDEX

m27

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

PRIMARY

Merck Index

NCI_THESAURUS

C74253

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

PRIMARY

PUBCHEM

10832

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

PRIMARY

ChEMBL

CHEMBL13589

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

PRIMARY

CAS

537-17-7

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

PRIMARY

EVMPD

SUB05388MIG

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

PRIMARY

EPA CompTox

DTXSID5046190

Created by admin on Wed Apr 02 10:00:29 GMT 2025 , Edited by admin on Wed Apr 02 10:00:29 GMT 2025

PRIMARY

Related Record Type Details


					X43W7JDA8L

AMANOZINE

ACTIVE MOIETY